HS-10529

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-10529, covering 2025-05-09 to 2025-05-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HS-10529 in KRAS G12D Patients With Advanced Solid Tumors [Phase 1]